Refresh

Surya Pharmaceuticals Ltd. - Research Center

532516 SURYAPHARM Group (Z) BSE data
Back to Company

Results

Statement

More

Half Yearly results in brief
(Rs crore)
Sep ' 13 Sep ' 12 Mar ' 12 Sep ' 11 Mar ' 11

Sales

10.32 46.50 762.99 882.53 844.91

Operating profit

-6.24 -41.43 21.84 151.71 134.50

Interest

131.08 107.08 97.76 83.58 58.18

Gross profit

-137.33 -147.54 -71.06 68.13 81.17

EPS (Rs)

-8.32 -8.18 -4.39 2.54 2.90
Half yearly  results in details
Sep ' 13 Sep ' 12 Mar ' 12 Sep ' 11 Mar ' 11

Other income

- 0.97 4.85 - 4.84

Stock adjustment

12.96 -16.87 -43.77 -116.76 -140.58

Raw material

0.19 82.29 686.26 784.57 792.78

Power and fuel

- - - - -

Employee expenses

0.84 6.52 21.77 21.69 23.34

Excise

- - - - -

Admin and selling expenses

- - - - -

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

2.57 16.00 76.88 41.32 34.86

Provisions made

- - - - -

Depreciation

31.34 18.27 17.99 16.62 11.47

Taxation

- - - - 13.89

Net profit / loss

-168.66 -165.81 -89.05 51.51 55.81

Extra ordinary item

- - - - -

Prior year adjustments

- - - - -

Equity capital

20.28 20.28 20.28 20.28 19.28

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

1597.14 1597.14 1254.89 1254.89 1254.89

Agg.of non promotoholding (%)

78.77 78.77 61.89 61.89 65.10

OPM (%)

-60.48 -89.11 2.86 17.19 15.92

GPM (%)

- -310.84 -9.26 - 9.55

NPM (%)

- -349.33 -11.60 - 6.57
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com